0000950170-24-094042.txt : 20240808 0000950170-24-094042.hdr.sgml : 20240808 20240808162009 ACCESSION NUMBER: 0000950170-24-094042 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20240808 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240808 DATE AS OF CHANGE: 20240808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MARCHEX INC CENTRAL INDEX KEY: 0001224133 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 352194038 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-50658 FILM NUMBER: 241188707 BUSINESS ADDRESS: STREET 1: 1200 FIFTH AVE STREET 2: SUITE 1300 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: 206-331-3300 MAIL ADDRESS: STREET 1: 1200 FIFTH AVE STREET 2: SUITE 1300 CITY: SEATTLE STATE: WA ZIP: 98101 8-K 1 mchx-20240808.htm 8-K 8-K
0001224133false00012241332024-08-082024-08-08

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 8, 2024

Marchex, Inc.

(Exact name of Registrant as Specified in its Charter)

Delaware

000-50658

35-2194038

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

 

1200 5th Ave., Suite 1300,

Seattle, Washington

98101

(Address of principal executive offices)

(Zip Code)

Registrant’s Telephone Number, Including Area Code: (206) 331-3300

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading

Symbol(s)

 

Name of each exchange on which registered

Class B Common Stock, par value $0.01 per share

 

MCHX

 

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition.

On August 8, 2024, Marchex, Inc. (“Marchex”) is issuing a press release and holding a conference call regarding its financial results for the second quarter ended June 30, 2024 (the “Press Release”). The full text of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 (including Exhibit 99.1) is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Marchex is referencing non-GAAP financial information in both the Press Release and on the conference call. A reconciliation of these non-GAAP financial measures to the comparable GAAP financial measures is contained in the attached Press Release. Disclosures regarding definitions of these financial measures used by Marchex and why Marchex’s management believes these financial measures provide useful information to investors is also included in the Press Release.

 

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit

No.

Description

 

 

99.1

Press Release of Marchex, dated August 8, 2024

104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, Marchex has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

MARCHEX, INC.

 

 

Date: August 8, 2024

By:

/s/ HOLLY A. AGLIO

 

Name:

Holly A. Aglio

 

Title:

Chief Financial Officer

(Principal Financial Officer)

 

 EX-99.1 2 mchx-ex99_1.htm EX-99.1 EX-99.1

Exhibit 99.1

Marchex Announces Second Quarter 2024 Results

SEATTLE, WA – August 8, 2024 – Marchex, Inc. (NASDAQ: MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the second quarter ended June 30, 2024.

Q2 2024 Financial Highlights

•
GAAP revenue was $12.1 million for the second quarter of 2024, compared to $12.5 million for the second quarter of 2023.
•
Net loss was $0.8 million for the second quarter of 2024 or $0.02 per diluted share, compared to a net loss of $2.7 million or $0.06 per diluted share for the second quarter of 2023.

 

 

 

Q2 2023

 

Q2 2024

GAAP Revenue

 

$ 12.5 million

 

$ 12.1 million

Non-GAAP Results:

 

 

 

 

Adjusted EBITDA

 

$ (1.0) million

 

$ 0.3 million

 

•
Adjusted non-GAAP loss per share for the second quarter of 2024 was ($0.01) compared to ($0.03) for the second quarter of 2023.

 

Recent Business Highlights:

•
New Customer Traction and Existing Customer Expansion. During the quarter, the company made progress in adding relationships in the Auto and Auto Services verticals as well as in expanding existing relationships in the Home Services vertical. The company continues to make progress expanding its pipeline of opportunities across multiple verticals.
•
Conversation Volumes. Overall conversation volumes in the second quarter were up somewhat from first quarter of 2024 levels.
•
Product Innovation. Marchex recently announced that it has won two additional industry awards: The AI Breakthrough Award for "Best Text Generative AI Solution" and the APPEALIE SaaS Customer Success award. The company continues to be recognized for its innovation with its Call Summaries and Sentiment Suite offering and its commitment to customer success.

 

“Our business is making significant progress across the key initiatives that we believe will enable Marchex to become an industry leading prescriptive analytics company," said Edwin Miller, CEO. “From the strides we are making with our OneStack initiative to the continued development of our sales pipeline, we are putting the pieces in place to harness our industry leading vertical market data and accelerate the business. We believe that we are on target with our margin and profitability goals for the year and that we are setting a strong foundation for future growth."

 

Business Outlook

 

The following forward-looking statements reflect Marchex's expectations as of ​August 8, 2024​.

 

For the third quarter ending September 30, 2024:

•
Revenue is anticipated to increase to be in the range of $12.6 million or more.
•
Adjusted EBITDA is anticipated to be in the range of or better than second quarter 2024 results.

 

“We are upgrading our technical foundation to accelerate future AI-powered product innovations while delivering against our targets to improve the financial outlook for the business. Additionally, based on current progress, we believe we are in a strong position to see sequential growth in the third quarter, deliver greater overall operating leverage in the business and meet or exceed our target for gross margin improvement for the year,” said Miller.

 

Management will hold a conference call, starting at 5:00 p.m. ET on Thursday, August 8, 2024​, to discuss its ​second quarter 2024 financial results and other company updates. Access to the live webcast of the conference call will be available online from the Investors section of Marchex’s website at www.marchex.com. An archived version of the webcast will also be available at the same location two hours after completion of the call.

 

About Marchex

 

Marchex harnesses the power of AI and conversational intelligence to provide actionable insights aligned with prescriptive vertical market data analytics, driving operational excellence and revenue acceleration. Marchex enables executive, sales, and marketing teams to optimize customer journey experiences across communication channels. Through our prescriptive analytics solutions, we enable the alignment of enterprise strategy, empowering businesses to increase revenue through informed decision-making and strategic execution. Marchex provides conversational intelligence AI-powered solutions for market-leading companies in leading B2B2C vertical markets, including several of the world’s most innovative and successful brands.

Please visit http://www.marchex.com, www.marchex.com/blog or @marchex on X (formally known as Twitter), where Marchex discloses material information from time to time about the company, its financial information, and its business.

Forward-Looking Statements:

 

This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding our strategy, future operations, future financial position, future revenues, other financial guidance, acquisitions, dispositions, projected costs, prospects, plans and objectives of management are forward-looking statements. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. There are a number of important factors that could cause Marchex's actual results to differ materially from those indicated by such forward-looking statements including but not limited to product demand, order cancellations and delays, competition and general economic conditions. These factors are described in greater detail in the "Risk Factors" section of our most recent periodic report and registration statement filed with the SEC. All of the information provided in this release is as of ​August 8, 2024,​ and Marchex undertakes no duty to update the information provided herein.

 

In the event the press release contains links to third party websites or materials, the links are provided solely as a convenience to you. Marchex is not responsible for the content of linked third-party sites or materials and does not make any representations regarding the content or accuracy thereof.

 

Non-GAAP Financial Information:

To supplement Marchex's consolidated financial statements presented in accordance with GAAP and to provide clarity internally and externally, Marchex uses certain non-GAAP measures of financial performance and

 

liquidity, including Adjusted EBITDA, Adjusted OIBA, and Adjusted non-GAAP income (loss) per share. Financial analysts and investors may use Adjusted EBITDA and Adjusted OIBA to help with comparative financial evaluation to make informed investment decisions. Financial analysts and investors may use Adjusted non-GAAP income (loss) per share to analyze Marchex's financial performance since these groups have historically used EPS related measures, along with other measures, to estimate the value of a company, to make informed investment decisions, and to evaluate a company's operating performance compared to that of other companies in its industry.

 

Adjusted EBITDA represents net income (loss) before (1) interest, (2) income taxes, (3) amortization of intangible assets from acquisitions, (4) depreciation and amortization, (5) stock-based compensation expense, and (6) acquisition and disposition-related costs. Adjusted EBITDA is an alternative measure used by our management to understand and evaluate our core operating performance and trends, and management believes it provides meaningful supplemental information regarding the company's liquidity and ability to fund its operations and financing obligations.

 

Adjusted OIBA represents Adjusted EBITDA adjusted for depreciation and amortization. This measure, among other things, is another metric by which Marchex has evaluated the performance of its business, to include being the basis on which Marchex's internal budgets have been based and by which Marchex's management has been evaluated. This measure represents Marchex's consolidated operating results, taking into account depreciation and other intangible amortization, but excluding the effects of certain other expenses removed in arriving at Adjusted EBITDA, as detailed above.

 

Adjusted non-GAAP income (loss) per share represents Adjusted non-GAAP income (loss) divided by GAAP diluted shares outstanding. Adjusted non-GAAP income (loss) generally captures those items on the statement of operations that have been, or ultimately will be, settled in cash exclusive of certain items that are not indicative of Marchex’s recurring core operating results and represents net income (loss) applicable to common stockholders plus the net of tax effects of: (1) stock-based compensation expense, (2) acquisition and disposition related costs, (3) amortization of intangible assets from acquisitions, and (4) interest (income) expense and other, net.

 

Marchex's management believes that investors should have access to, and Marchex is obligated to provide, the same set of tools that management uses in analyzing the company's results. These non-GAAP measures should be considered in addition to results prepared in accordance with GAAP, and should not be considered in isolation, as a substitute for, or superior to, GAAP results. Marchex’s non-GAAP financial measures may be defined differently from time to time and may be defined differently than similar titled terms used by other companies, and accordingly, care should be exercised in understanding how Marchex defines its non-GAAP financial measures in this release. Marchex endeavors to compensate for the limitations of the non-GAAP measures presented by providing the comparable GAAP measure with equal or greater prominence, GAAP financial statements, and detailed descriptions of the reconciling items and adjustments, including quantifying such items, to derive the non-GAAP measure.

 

For further information, contact:

Trevor Caldwell
Marchex Investor Relations

Telephone: 206.331.3600
Email: ir@marchex.com

Or

MEDIA INQUIRIES

Marchex Corporate Communications

Telephone: 206.331.3434

Email: pr(at)marchex.com

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MARCHEX, INC. AND SUBSIDIARIES

Condensed Consolidated Statements of Operations

(in thousands, except per share amounts)

(unaudited)

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2023

 

 

2024

 

 

2023

 

 

2024

 

Revenue

 

$

12,522

 

 

$

12,074

 

 

$

24,738

 

 

$

23,646

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Service costs (1)

 

 

5,418

 

 

 

4,152

 

 

 

10,842

 

 

 

8,566

 

Sales and marketing (1)

 

 

2,631

 

 

 

2,742

 

 

 

6,601

 

 

 

5,529

 

Product development (1)

 

 

4,096

 

 

 

3,223

 

 

 

8,260

 

 

 

6,468

 

General and administrative (1)

 

 

2,546

 

 

 

2,528

 

 

 

5,163

 

 

 

4,817

 

Amortization of intangible assets from acquisitions

 

 

531

 

 

 

151

 

 

 

1,062

 

 

 

301

 

Acquisition and disposition related costs

 

 

(1

)

 

 

—

 

 

 

12

 

 

 

—

 

Total operating expenses

 

 

15,221

 

 

 

12,796

 

 

 

31,940

 

 

 

25,681

 

 Loss from operations

 

 

(2,699

)

 

 

(722

)

 

 

(7,202

)

 

 

(2,035

)

Interest income (expense) and other, net

 

 

(31

)

 

 

(31

)

 

 

26

 

 

 

(109

)

Loss before provision for income taxes

 

 

(2,730

)

 

 

(753

)

 

 

(7,176

)

 

 

(2,144

)

Income tax expense

 

 

14

 

 

 

3

 

 

 

44

 

 

 

62

 

Net loss applicable to common stockholders

 

$

(2,744

)

 

$

(756

)

 

$

(7,220

)

 

$

(2,206

)

Basic and diluted net loss per Class A and Class B share applicable to common stockholders

 

$

(0.06

)

 

$

(0.02

)

 

$

(0.17

)

 

$

(0.05

)

 

 

 

 

 

 

 

 

 

 

 

 

Shares used to calculate basic net loss per share applicable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

 

4,661

 

 

 

4,661

 

 

 

4,661

 

 

 

4,661

 

Class B

 

 

37,840

 

 

 

38,403

 

 

 

37,837

 

 

 

38,398

 

Shares used to calculate diluted net loss per share applicable to common stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

Class A

 

 

4,661

 

 

 

4,661

 

 

 

4,661

 

 

 

4,661

 

Class B

 

 

42,501

 

 

 

43,064

 

 

 

42,498

 

 

 

43,059

 

(1) Includes stock-based compensation allocated as follows:

 

 

 

 

 

 

 

 

 

 

 

 

Service costs

 

$

(45

)

 

$

3

 

 

$

—

 

 

$

6

 

Sales and marketing

 

 

228

 

 

 

88

 

 

 

491

 

 

 

176

 

Product development

 

 

47

 

 

 

14

 

 

 

133

 

 

 

22

 

General and administrative

 

 

471

 

 

 

333

 

 

 

876

 

 

 

666

 

Total

 

$

701

 

 

$

438

 

 

$

1,500

 

 

$

870

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

MARCHEX, INC. AND SUBSIDIARIES

Condensed Consolidated Balance Sheets

(in thousands)

(unaudited)

 

 

 

December 31,

 

 

June 30,

 

 

 

2023

 

 

2024

 

Assets

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

14,607

 

 

$

11,977

 

Accounts receivable, net

 

 

7,394

 

 

 

7,636

 

Prepaid expenses and other current assets

 

 

1,805

 

 

 

2,874

 

Total current assets

 

 

23,806

 

 

 

22,487

 

Property and equipment, net

 

 

2,398

 

 

 

1,861

 

Other assets, net

 

 

1,482

 

 

 

1,900

 

Right-of-use lease asset

 

 

1,631

 

 

 

1,397

 

Goodwill

 

 

17,558

 

 

 

17,558

 

Intangible assets from acquisitions, net

 

 

602

 

 

 

301

 

Total assets

 

$

47,477

 

 

$

45,504

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Accounts payable

 

$

1,533

 

 

$

1,921

 

Accrued benefits and payroll

 

 

3,294

 

 

 

2,138

 

Other accrued expenses and current liabilities

 

 

3,217

 

 

 

3,453

 

Deferred revenue and deposits

 

 

1,214

 

 

 

1,470

 

Lease liability current

 

 

462

 

 

 

486

 

Total current liabilities

 

 

9,720

 

 

 

9,468

 

Deferred tax liabilities

 

 

249

 

 

 

278

 

Finance lease, non-current

 

 

421

 

 

 

256

 

Lease liability, non-current

 

 

1,217

 

 

 

967

 

Total liabilities

 

 

11,607

 

 

 

10,969

 

Stockholders’ equity:

 

 

 

 

 

 

Class A common stock

 

 

49

 

 

 

49

 

Class B common stock

 

 

386

 

 

 

389

 

Additional paid-in capital

 

 

356,666

 

 

 

357,534

 

Accumulated deficit

 

 

(321,231

)

 

 

(323,437

)

Total stockholders’ equity

 

 

35,870

 

 

 

34,535

 

Total liabilities and stockholders’ equity

 

$

47,477

 

 

$

45,504

 

 

 

MARCHEX, INC. AND SUBSIDIARIES

(in thousands)

(unaudited)

 

Reconciliation of GAAP Net Loss to Adjusted EBITDA and Adjusted Operating Income (Loss) Before Amortization (OIBA)

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2023

 

 

2024

 

 

2023

 

 

2024

 

Net loss applicable to common stockholders

 

$

(2,744

)

 

$

(756

)

 

$

(7,220

)

 

$

(2,206

)

Interest (income) expense and other, net

 

 

31

 

 

 

31

 

 

 

(26

)

 

 

109

 

Income tax expense

 

 

14

 

 

 

3

 

 

 

44

 

 

 

62

 

Amortization of intangible assets from acquisitions

 

 

531

 

 

 

151

 

 

 

1,062

 

 

 

301

 

Depreciation and amortization

 

 

422

 

 

 

385

 

 

 

780

 

 

 

708

 

Stock-based compensation

 

 

701

 

 

 

438

 

 

 

1,500

 

 

 

870

 

Acquisition and disposition-related costs

 

 

(1

)

 

 

—

 

 

 

12

 

 

 

—

 

Adjusted EBITDA

 

$

(1,046

)

 

$

252

 

 

$

(3,848

)

 

$

(156

)

Depreciation and amortization

 

 

422

 

 

 

385

 

 

 

780

 

 

 

708

 

Adjusted OIBA

 

$

(1,468

)

 

$

(133

)

 

$

(4,628

)

 

$

(864

)

 

 

 

MARCHEX, INC. AND SUBSIDIARIES

(in thousands)

(unaudited)

 

Reconciliation of GAAP Net Loss per Share to Adjusted Non-GAAP Loss1

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2023

 

 

2024

 

 

2023

 

 

2024

 

Net loss applicable to common stockholders, diluted

 

$

(0.06

)

 

$

(0.02

)

 

$

(0.17

)

 

$

(0.05

)

Stock-based compensation

 

 

0.02

 

 

 

0.01

 

 

 

0.03

 

 

 

0.02

 

Acquisition and disposition-related costs

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Amortization of intangible assets from acquisitions

 

 

0.01

 

 

 

-

 

 

 

0.03

 

 

 

0.01

 

Interest (income) expense and other, net

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Adjusted non-GAAP loss per share

 

$

(0.03

)

 

$

(0.01

)

 

$

(0.11

)

 

$

(0.02

)

Shares used to calculate diluted net loss per share applicable to common stockholders (GAAP) and Adjusted Non-GAAP loss per share

 

 

42,501

 

 

 

43,064

 

 

 

42,498

 

 

 

43,059

 

 

1 For the purpose of computing the number of diluted shares for Adjusted non-GAAP income (loss) per share, Marchex uses the accounting guidance that would be applicable for computing the number of diluted shares for GAAP net income (loss) per share.

 

 EX-101.SCH 3 mchx-20240808.xsd XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 100000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Central Index Key Entity Central Index Key Entity Address, State or Province Entity Address, State or Province Cover Cover [Abstract] Entity Address, Address Line One Entity Address, Address Line One Amendment Flag Amendment Flag Entity Address, City or Town Entity Address, City or Town Document Type Document Type Title of 12(b) Security Title of 12(b) Security Soliciting Material Soliciting Material Entity Address, Address Line Two Entity Address, Address Line Two Document Period End Date Document Period End Date Trading Symbol Trading Symbol Pre-commencement Tender Offer Pre-commencement Tender Offer Security Exchange Name Security Exchange Name Written Communications Written Communications Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Registrant Name Entity Registrant Name Entity Emerging Growth Company Entity Emerging Growth Company Securities Act File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number City Area Code City Area Code Local Phone Number Local Phone Number XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Document and Entity Information
Aug. 08, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 08, 2024
Entity Registrant Name Marchex, Inc.
Entity Central Index Key 0001224133
Entity Emerging Growth Company false
Entity File Number 000-50658
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 35-2194038
Entity Address, Address Line One 1200 5th Ave
Entity Address, Address Line Two Suite 1300
Entity Address, City or Town Seattle
Entity Address, State or Province WA
Entity Address, Postal Zip Code 98101
City Area Code 206
Local Phone Number 331-3300
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class B Common Stock, par value $0.01 per share
Trading Symbol MCHX
Security Exchange Name NASDAQ
EXCEL 6 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 7 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 8 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2.u1 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports mchx-20240808.htm mchx-20240808.xsd http://xbrl.sec.gov/dei/2024 false false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "mchx-20240808.htm": { "nsprefix": "mchx", "nsuri": "http://www.marchex.com/20240808", "dts": { "inline": { "local": [ "mchx-20240808.htm" ] }, "schema": { "local": [ "mchx-20240808.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 23 }, "report": { "R1": { "role": "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "C_bfa66d52-ca58-4dba-8f5a-c4bddeb91e73", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mchx-20240808.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "C_bfa66d52-ca58-4dba-8f5a-c4bddeb91e73", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "mchx-20240808.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Securities Act File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.marchex.com/20240808/taxonomy/role/Role_DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 13 0000950170-24-094042-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000950170-24-094042-xbrl.zip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end XML 14 mchx-20240808_htm.xml IDEA: XBRL DOCUMENT 0001224133 2024-08-08 2024-08-08 0001224133 false 8-K 2024-08-08 Marchex, Inc. DE 000-50658 35-2194038 1200 5th Ave Suite 1300 Seattle WA 98101 206 331-3300 false false false false Class B Common Stock, par value $0.01 per share MCHX NASDAQ false